Press "Enter" to skip to content

New patent for Bayer Healthcare drug NUBEQA

1
Copyright © DrugPatentWatch. Originally published at New patent for Bayer Healthcare drug NUBEQA

Annual Drug Patent Expirations for NUBEQA
Annual Drug Patent Expirations for NUBEQA

Nubeqa is a drug marketed by Bayer Healthcare and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

This drug has forty-five patent family members in thirty-three countries.

The generic ingredient in NUBEQA is darolutamide. One supplier is listed for this compound. Additional details are available on the darolutamide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Bayer Healthcare drug NUBEQA
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    Do NOT follow this link or you will be banned from the site!